LLY

1,069.6

+1.01%↑

JNJ

205.19

+0.62%↑

ABBV

234.02

-0.91%↓

UNH

320.5

+0.36%↑

AZN

91.47

+0.51%↑

LLY

1,069.6

+1.01%↑

JNJ

205.19

+0.62%↑

ABBV

234.02

-0.91%↓

UNH

320.5

+0.36%↑

AZN

91.47

+0.51%↑

LLY

1,069.6

+1.01%↑

JNJ

205.19

+0.62%↑

ABBV

234.02

-0.91%↓

UNH

320.5

+0.36%↑

AZN

91.47

+0.51%↑

LLY

1,069.6

+1.01%↑

JNJ

205.19

+0.62%↑

ABBV

234.02

-0.91%↓

UNH

320.5

+0.36%↑

AZN

91.47

+0.51%↑

LLY

1,069.6

+1.01%↑

JNJ

205.19

+0.62%↑

ABBV

234.02

-0.91%↓

UNH

320.5

+0.36%↑

AZN

91.47

+0.51%↑

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Отворен

СекторЗдравеопазване

16.62 0.79

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

16.49

Максимум

16.85

Ключови измерители
By Trading Economics
Приходи	10M -33M
Продажби	-435K 54M
Марж на печалбата	-60.369
Служители	891
EBITDA	10M -31M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+60.9% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-226M 1.3B
Предишно отваряне	15.83
Предишно затваряне	16.62

Настроения в новините

By Acuity

33%

67%

70 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.11.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

BHP Abandons Bid for Anglo American Following New Talks

23.11.2025 г., 22:16 ч. UTC

Придобивния, сливания и поглъщания

Macquarie Proposes $7.5 Billion Takeover of Logistics Operator Qube

23.11.2025 г., 22:01 ч. UTC

Придобивния, сливания и поглъщания

Macquarie Proposes $7.5B Takeover of Logistics Operator Qube

23.11.2025 г., 19:00 ч. UTC

Печалби

Dell, HP Inc., Alibaba, Zoom, Deere, and More Stocks to Watch This Week -- Barrons.com

23.11.2025 г., 00:50 ч. UTC

Печалби

Wall Street Goes on a Wild Ride: 'No One Was Expecting This' -- WSJ

22.11.2025 г., 10:30 ч. UTC

Печалби

How Google Finally Leapfrogged Rivals With New Gemini Rollout -- WSJ

22.11.2025 г., 10:30 ч. UTC

Придобивния, сливания и поглъщания

Investors Clamor for a Peek Behind the Private Markets Curtain -- WSJ

22.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

21.11.2025 г., 22:42 ч. UTC

Пазарно говорене

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

21.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

21.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

21.11.2025 г., 21:47 ч. UTC

Пазарно говорене

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

21.11.2025 г., 21:43 ч. UTC

Пазарно говорене

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

21.11.2025 г., 20:18 ч. UTC

Пазарно говорене

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

21.11.2025 г., 20:14 ч. UTC

Пазарно говорене

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

21.11.2025 г., 19:48 ч. UTC

Пазарно говорене

Precious Metals Fall for the Week -- Market Talk

21.11.2025 г., 19:44 ч. UTC

Печалби

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

21.11.2025 г., 19:37 ч. UTC

Пазарно говорене

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

21.11.2025 г., 19:27 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

21.11.2025 г., 19:27 ч. UTC

Пазарно говорене

Печалби

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

21.11.2025 г., 19:20 ч. UTC

Пазарно говорене

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

21.11.2025 г., 18:44 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

21.11.2025 г., 18:37 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

21.11.2025 г., 18:34 ч. UTC

Пазарно говорене

Печалби

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

21.11.2025 г., 18:28 ч. UTC

Печалби

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

21.11.2025 г., 18:03 ч. UTC

Пазарно говорене

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

21.11.2025 г., 17:24 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

21.11.2025 г., 17:24 ч. UTC

Пазарно говорене

Intuit Seen on Path to Increase Growth -- Market Talk

21.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

21.11.2025 г., 17:05 ч. UTC

Пазарно говорене

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

60.9% нагоре

12-месечна прогноза

Среден 26.5 USD 60.9%

Висок 33 USD

Нисък 21 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

70 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.